Here we demonstrate that pharmacological inhibition of TrxR or lentiviral knock-down of TrxR2 sensitizes dopaminergic cells to sub-toxic concentrations of PD toxicants PQ and 6OHDA. This evidence concerns the gene TXNRD2 and Parkinson disease.